BioStem Technologies, Inc.
BSEM
$3.71
$0.102.77%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -84,735.85% | -325.68% | -176.78% | -88.84% | -99.83% |
| Total Depreciation and Amortization | 725.06% | 658.39% | 50.31% | 83.23% | 0.89% |
| Total Amortization of Deferred Charges | -- | -- | -100.00% | -100.00% | -81.97% |
| Total Other Non-Cash Items | 23.99% | -20.79% | 1,121.90% | 42.68% | 76.18% |
| Change in Net Operating Assets | -109.34% | 406.68% | 94.62% | -416.07% | 290.87% |
| Cash from Operations | -202.14% | -120.26% | -65.29% | -125.31% | -14.57% |
| Capital Expenditure | 83.12% | 98.91% | -232.67% | -1,919.72% | -103.68% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 200.00% | -- |
| Cash from Investing | 83.12% | -9,019.73% | -232.67% | 14.76% | -103.68% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -280.60% | -- | 100.00% | -42.99% | -260.63% |
| Issuance of Common Stock | -- | -- | -100.00% | -85.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -24.65% | -- | -100.00% | -2,655.10% | -260.63% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -261.64% | -512.57% | -70.91% | -145.84% | -29.66% |